Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 201

    1.

    Surveillance for endometrial cancer in women receiving tamoxifen.

    Suh-Burgmann EJ, Goodman A.

    Ann Intern Med. 1999 Jul 20;131(2):127-35. Review.PMID: 10419429 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Risk of endometrial cancer in breast cancer patients under long-term adjuvant treatment with tamoxifen.

    Cecchini S, Ciatto S, Bonardi R, Mazzotta A, Pacini P, Muraca MG, Zappa M.

    Tumori. 1998 Jan-Feb;84(1):21-3.PMID: 9619708 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.

    Fung MF, Reid A, Faught W, Le T, Chenier C, Verma S, Brydon E, Fung KF.

    Gynecol Oncol. 2003 Oct;91(1):154-9.PMID: 14529676 [PubMed - indexed for MEDLINE]Related articles

    4.

    Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening.

    Love CD, Muir BB, Scrimgeour JB, Leonard RC, Dillon P, Dixon JM.

    J Clin Oncol. 1999 Jul;17(7):2050-4.PMID: 10561257 [PubMed - indexed for MEDLINE]Related articles

    5.

    Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment.

    Creasman WT.

    Semin Oncol. 1997 Feb;24(1 Suppl 1):S1-140-S1-50. Review.PMID: 9045311 [PubMed - indexed for MEDLINE]Related articles

    6.

    Tamoxifen therapy for breast cancer and endometrial cancer risk.

    Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E, Perlman JA, Ford L.

    J Natl Cancer Inst. 1999 Oct 6;91(19):1654-62.PMID: 10511593 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Indication of hysteroscopy in tamoxifen treated breast cancer patients.

    Taponeco F, Curcio C, Fasciani A, Giuntini A, Artini PG, Fornaciari G, Petraglia F, Genazzani AR.

    J Exp Clin Cancer Res. 2002 Mar;21(1):37-43.PMID: 12071527 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effects of tamoxifen treatment on the endometrium.

    Daniel Y, Inbar M, Bar-Am A, Peyser MR, Lessing JB.

    Fertil Steril. 1996 Jun;65(6):1083-9. Review.PMID: 8641477 [PubMed - indexed for MEDLINE]Related articles

    9.

    Guidelines for monitoring patients taking tamoxifen treatment.

    Neven P, Vernaeve H.

    Drug Saf. 2000 Jan;22(1):1-11. Review.PMID: 10647972 [PubMed - indexed for MEDLINE]Related articles

    10.

    Endometrial changes with chronic tamoxifen use.

    Loret de Mola JR.

    Curr Opin Obstet Gynecol. 1997 Jun;9(3):160-4. Review.PMID: 9263698 [PubMed - indexed for MEDLINE]Related articles

    11.

    Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.

    Sinawat S, Chiyabutra T, Kleabkaew P.

    J Med Assoc Thai. 2001 Jul;84(7):1033-6.PMID: 11759963 [PubMed - indexed for MEDLINE]Related articles

    12.

    Tamoxifen-induced endometrial cancer.

    Chen P, Yang CC, Chen YJ, Wang PH.

    Eur J Gynaecol Oncol. 2003;24(2):135-7.PMID: 12701962 [PubMed - indexed for MEDLINE]Related articles

    13.

    Screening and the prevention of gynecologic cancer: endometrial cancer.

    Sonoda Y, Barakat RR.

    Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):363-77. Epub 2005 Dec 20. Review.PMID: 16364689 [PubMed - indexed for MEDLINE]Related articles

    14.

    Tamoxifen and endometrial cancer. Is screening necessary? A review of the literature.

    Machado F, Rodríguez JR, León JP, Rodríguez JR, Parrilla JJ, Abad L.

    Eur J Gynaecol Oncol. 2005;26(3):257-65. Review.PMID: 15991522 [PubMed - indexed for MEDLINE]Related articles

    15.

    Surveillance of the endometrium in tamoxifen treated women.

    Cardosi RJ, Fiorica JV.

    Curr Opin Obstet Gynecol. 2000 Feb;12(1):27-31. Review.PMID: 10752513 [PubMed - indexed for MEDLINE]Related articles

    16.

    Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.

    Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE.

    Lancet. 2000 Sep 9;356(9233):881-7.PMID: 11036892 [PubMed - indexed for MEDLINE]Related articles

    17.

    Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.

    Bornstein J, Auslender R, Pascal B, Gutterman E, Isakov D, Abramovici H.

    J Reprod Med. 1994 Sep;39(9):674-8.PMID: 7807477 [PubMed - indexed for MEDLINE]Related articles

    18.

    Benign and hyperplastic endometrial changes associated with tamoxifen use.

    Barakat RR.

    Oncology (Williston Park). 1997 Feb;11(2 Suppl 1):35-7. Review.PMID: 9065925 [PubMed - indexed for MEDLINE]Related articles

    19.

    Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen.

    Sinawat S, Chiyabutra T, Kleabkaew P.

    Asian Pac J Cancer Prev. 2003 Aug-Dec;4(4):327-30.PMID: 14728591 [PubMed - indexed for MEDLINE]Related articles

    20.

    Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

    Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J, Fondrinier E, Lefeuvre C, Parache RM, Chauvin F.

    Int J Cancer. 1998 May 4;76(3):325-30.PMID: 9579567 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data